Skip to content

ADMA生物制品

US · ADMA #2705 按市值排名 上市于 1970
10.68 -0.05 -0.47%
实时 - 追踪5344个代码 - 心跳于193秒前 · 2026-10-16 20:02

✦ 量化股权信号 计算方式说明

增持
  • 最近一期(2026/Q3)披露持股的机构数量减少了2家。
  • 机构持股总比例上升了0.4个百分点。

机构持股

机构持股比例
91.64% +0.40pp
机构数量
375 -2
数据截至
2026/Q3 较上一报告期

持股变动 vs 资金流向

方向分歧

机构在上一报告期增持了股份,同时该股在最近20个交易日的主力资金呈净流出——两者方向出现分歧。

机构持股变动数据按季度发布且存在滞后;资金流向数据为每日更新。请将其作为方向性的交叉验证参考,而非精确的择时信号。

持股人类型

Mutual Fund64.67%
Hedge Fund17.89%
Public Company3.43%
Individual/Insider1.89%
Private Company1.51%
Government Pension Fund1.50%
Family Office/Trust1.32%
VC/PE Fund1.11%
Other6.59%

主要股东 截至 2026-06-30

BlackRock 17.12% · 38.36M 股
State Street Global Advisors 7.64% · 17.12M 股
Vanguard Capital Management, LLC 5.25% · 11.76M 股
Vanguard Portfolio Management, LLC 4.50% · 10.09M 股
Rubric Capital Management LP 4.17% · 9.34M 股
Capital Research 3.91% · 8.76M 股
First Trust Advisors L.P. 3.48% · 7.80M 股
Geode Capital Management, LLC 2.71% · 6.06M 股
Caligan Partners, LP 2.56% · 5.73M 股
D. E. Shaw & Co., L.P. 2.35% · 5.27M 股

条形长度是相对于此处列出的最大股东而言,并非相对于公司100%股权。

内部人持股

共追踪50份申报 · 23次买入 · 25次卖出

姓名职务持股比例
Adam Grossman Chief Executive Officer 1.31%
Jerrold Grossman Co-Founder & Vice Chairman of the Board 0.25%
Young Kwon Independent Director 0.11%
Lawrence Guiheen Independent Director 0.08%
Kaitlin Kestenberg Senior Vice President of Compliance & Project Operations 0.07%
Steven Elms Independent Chairperson 0.04%
Alison Finger Director 0.02%
Eduardo Salas Director 0.00%
Brad Tade Vice President of Financial Operations 0.00%
P. Terence Kohler Chief Financial Officer --

内部人交易 最近的 Form 4 申报记录

日期姓名职务类型股数价格
2026-07-23 Kaitlin Kestenberg Senior Vice President of Compliance & Project Operations Sale to Issuer -3,177 $8.37
2026-07-15 P. Terence Kohler Chief Financial Officer Other Acquisition +85,130 --
2026-07-15 P. Terence Kohler Chief Financial Officer Other Derivative Acquisition +136,363 $8.81
2026-05-26 Jerrold Grossman Co-Founder & Vice Chairman of the Board Open Market Acquisition +6,400 $7.91
2026-05-11 Jerrold Grossman Co-Founder & Vice Chairman of the Board Open Market Acquisition +12,500 $8.01
2026-05-10 Jerrold Grossman Co-Founder & Vice Chairman of the Board Open Market Acquisition +12,500 $8.01
2026-03-31 Kaitlin Kestenberg Senior Vice President of Compliance & Project Operations Sale to Issuer -20,362 $9.11
2026-03-16 Lawrence Guiheen Independent Director Derivative Exercise and Sale -30,000 --
2026-03-16 Lawrence Guiheen Independent Director Other Acquisition +30,000 --
2026-03-15 Adam Grossman Chief Executive Officer Automatic Disposition -6,000 $15.16
2026-03-15 Adam Grossman Chief Executive Officer Derivative Exercise and Sale -15,000 $5.40–15.16
2026-03-09 Brad Tade Vice President of Financial Operations Intent to Sell (Form 144) -50,026 $15.81
2026-03-08 Kaitlin Kestenberg Senior Vice President of Compliance & Project Operations Other Disposition -91,266 --
2026-03-08 Kaitlin Kestenberg Senior Vice President of Compliance & Project Operations Derivative Exercise and Sale -10,096 $1.55–15.63
2026-03-06 Adam Grossman Chief Executive Officer Sale to Issuer -85,951 $15.39
2026-03-06 Kaitlin Kestenberg Senior Vice President of Compliance & Project Operations Sale to Issuer -14,294 $15.39
2026-03-05 Aisling Capital Management LP -- Open Market Acquisition +14,000 $15.39–15.67
2026-02-25 P. Terence Kohler Chief Financial Officer Initial Statement of Beneficial 0 --
2026-02-25 Adam Grossman Chief Executive Officer Sale to Issuer -54,858 $15.18
2026-02-18 Adam Grossman Chief Executive Officer Sale to Issuer -24,793 $16.32

Form 4 申报记录,每家公司显示最新的一批。"Other Derivative Acquisition"(其他衍生品获取)类目多为限制性股票/期权归属,并非公开市场买入——具体类型见"类型"列。

报价时间 2026-10-16 20:02:19 · 仅供参考,不构成投资建议,也未考虑您的具体情况。

ADMA生物制品 讨论区 0 条评论

发表评论